AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
57.51
+0.74 (1.30%)
Jun 18, 2026, 4:00 PM EDT - Market closed
AnaptysBio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 232.39 | 234.6 | 91.28 | 17.16 | 10.29 | 63.18 | |
Revenue Growth (YoY) | 107.73% | 157.01% | 432.03% | 66.78% | -83.72% | -15.77% |
Gross Profit | 232.39 | 234.6 | 91.28 | 17.16 | 10.29 | 63.18 |
Selling, General & Admin | 62.81 | 50.74 | 42.39 | 41.95 | 36.64 | 21.49 |
Research & Development | 128.78 | 135.97 | 163.84 | 132.28 | 88.8 | 98.5 |
Other Operating Expenses | - | - | - | 7.34 | - | - |
Total Operating Expenses | 191.59 | 186.71 | 206.23 | 181.57 | 125.44 | 119.99 |
Operating Income | 40.8 | 47.9 | -114.95 | -164.41 | -115.15 | -56.81 |
Interest Income | 11.74 | 13.5 | 19.79 | 18.87 | 7.55 | 0.43 |
Interest Expense | -82.69 | -79.89 | -50.09 | -18.08 | -21.11 | -1.45 |
Other Non-Operating Income (Expense) | -63.9 | -55.53 | -30.27 | 0.79 | -13.53 | -0.95 |
Total Non-Operating Income (Expense) | -134.85 | -121.93 | -60.56 | 1.58 | -27.09 | -1.96 |
Pretax Income | -26.63 | -13.07 | -145.23 | -163.62 | -128.7 | -57.8 |
Provision for Income Taxes | -0.16 | -0.16 | -0 | 0 | -0.02 | - |
Net Income | -26.79 | -13.23 | -145.23 | -163.62 | -128.72 | -57.8 |
Net Income to Common | -26.79 | -13.23 | -145.23 | -163.62 | -128.72 | -57.8 |
Shares Outstanding (Basic) | 28 | 29 | 28 | 27 | 28 | 27 |
Shares Outstanding (Diluted) | 29 | 29 | 28 | 27 | 28 | 27 |
Shares Change (YoY) | 0.44% | 1.32% | 5.42% | -4.41% | 2.68% | 0.47% |
EPS (Basic) | -0.85 | -0.46 | -5.12 | -6.08 | -4.57 | -2.11 |
EPS (Diluted) | -1.08 | -0.46 | -5.12 | -6.08 | -4.57 | -2.11 |
Free Cash Flow | 4.41 | 19.61 | -135.7 | -121.61 | -73.95 | -47.29 |
Free Cash Flow Growth | -77.52% | - | - | - | - | - |
Free Cash Flow Per Share | 0.15 | 0.68 | -4.78 | -4.52 | -2.63 | -1.72 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | 17.56% | 20.42% | -125.93% | -958.27% | -1119.41% | -89.93% |
Profit Margin | -11.53% | -5.64% | -159.11% | -953.66% | -1251.33% | -91.49% |
FCF Margin | 1.90% | 8.36% | -148.66% | -708.79% | -718.88% | -74.85% |
EBITDA | 41.34 | 48.46 | -114.34 | -163.76 | -114.48 | -56.2 |
EBITDA Margin | 17.79% | 20.65% | -125.27% | -954.47% | -1112.85% | -88.95% |
EBIT | 40.8 | 47.9 | -114.95 | -164.41 | -115.15 | -56.81 |
EBIT Margin | 17.56% | 20.42% | -125.93% | -958.27% | -1119.41% | -89.93% |
Effective Tax Rate | 0.60% | 1.25% | 0.00% | -0.00% | 0.02% | 0.00% |